BVF PARTNERS L P/IL
Insider trades filed on SEC Form 4, newest first. SEC CIK 0001055947.
- 79
- Form 4 lines on record
- 3
- Purchases (code P)
- 22
- Sales (code S)
- Oct 5, 2026, 6:28 PM ET
- Latest filing
Companies BVF PARTNERS L P/IL reports for
- Foghorn Therapeutics Inc. FHTX, 10% OwnerLast filed Oct 5, 2026, 4:28 PM ET
- IMMUNIC, INC. IMUX, DirectorLast filed Sep 18, 2026, 7:45 PM ET
- XOMA Royalty Corp XOMA, 10% OwnerLast filed Jul 16, 2026, 5:02 PM ET
- Kymera Therapeutics, Inc. KYMR, DirectorLast filed Jun 26, 2026, 6:48 PM ET
- Olema Pharmaceuticals, Inc. OLMA, DirectorLast filed Jun 23, 2026, 5:52 PM ET
- MoonLake Immunotherapeutics MLTX, DirectorLast filed Jun 22, 2026, 4:50 PM ET
- Repare Therapeutics Inc. RPTX, 10% OwnerLast filed Jan 30, 2026, 6:44 PM ET
- ESSA Pharma Inc. EPIX, 10% OwnerLast filed Oct 14, 2025, 5:33 PM ET
- GLYCOMIMETICS INC CBIO, 10% OwnerLast filed Jun 17, 2025, 6:53 PM ET
- Allakos Inc. ALLK, 10% OwnerLast filed May 19, 2025, 6:45 PM ET
- PALVELLA THERAPEUTICS, INC. PVLALast filed Dec 17, 2024, 5:44 PM ET
- 4D Molecular Therapeutics, Inc. FDMTLast filed Nov 13, 2024, 4:33 PM ET
- Third Harmonic Bio, Inc. THRDLast filed Oct 31, 2024, 5:53 PM ET
- Eledon Pharmaceuticals, Inc. ELDN, 10% OwnerLast filed Oct 31, 2024, 5:52 PM ET
Holdings
LockedShares owned after each company's most recent Form 4, valued at the current price. Part of InsiderScanner.
- Filed Sep 18, 2026, 7:45 PM ET (open the Form 4 on EDGAR)Award/GrantOther
IMUXIMMUNIC, INC.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 26, 2026, 6:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
KYMRKymera Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 26, 2026, 6:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
KYMRKymera Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 26, 2026, 6:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
KYMRKymera Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 26, 2026, 6:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
KYMRKymera Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 25, 2026, 6:58 PM ET (open the Form 4 on EDGAR)Award/GrantOther
KYMRKymera Therapeutics, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 23, 2026, 5:52 PM ET (open the Form 4 on EDGAR)Award/GrantOther
OLMAOlema Pharmaceuticals, Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Jun 22, 2026, 4:50 PM ET (open the Form 4 on EDGAR)Award/GrantOther
MLTXMoonLake Immunotherapeutics
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 18, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Conversion of DerivativeOther
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 18, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Conversion of DerivativeOther
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 18, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Conversion of DerivativeOther
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed May 18, 2026, 5:29 PM ET (open the Form 4 on EDGAR)Conversion of DerivativeOther
XOMAXOMA Royalty Corp
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Apr 2, 2026, 4:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
MLTXMoonLake Immunotherapeutics
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Apr 2, 2026, 4:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
MLTXMoonLake Immunotherapeutics
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
- Filed Apr 2, 2026, 4:48 PM ET (open the Form 4 on EDGAR)Sale (code S)Sell
MLTXMoonLake Immunotherapeutics
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
RPTXRepare Therapeutics Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
RPTXRepare Therapeutics Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
RPTXRepare Therapeutics Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
EPIXESSA Pharma Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
EPIXESSA Pharma Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
EPIXESSA Pharma Inc.
- Shares
- Locked
- Price
- Locked
- Value
- Locked
- Traded
- Locked
- Owned after
- Locked
Shares, price, value, trade date and holdings after the trade are locked on 25 rows here. Included with InsiderScanner ($9.99 a month) and Signal8 Pro.
Unlock with InsiderScannerShowing the newest 25. There are about 54 more in this window; the full list is part of InsiderScanner.
Unlock with InsiderScanner